Hyperhomocyst(e)inemia: A risk factor for cerebrovascular disease

Clinical and Experimental Hypertension

Volumn 24, Issue 7-8, 2002, Pages 501-509

  Parnetti, Lucilla ^a   Caso, Valeria ^a   Amici, Serena ^a   Lanari, Alessia ^a   Gallai, Virgilio ^a   Bottiglieri, Teodoro ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONFERENCE PAPER; DISEASE ASSOCIATION; HUMAN; HYPERHOMOCYSTEINEMIA; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR; VASCULAR ENDOTHELIUM;

BIOLOGICAL MARKERS; CEREBROVASCULAR DISORDERS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0036815519     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-120015326     Document Type: Conference Paper

References (39)

1. Chiang, P.K.; Gordon, R.K.; Tal, J.; Zeng, G.C.; Doctor, B.P.; Pardhasaradhi, K.; McCann, P.P. S-adenosylmethionine and methylation. FASEB J. 1996, 10, 471-480.
2. Selhub, J.; Miller, J.W. The pathogenesis of hyperhomocyst(e)inemia, interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transulfuration of homocyst(e)ine. Am. J. Clin. Nutr. 1991, 55, 131-138.
3. Hankey, G.J.; Eikelboom, J.W. Homocyst(e)ine and vascular disease. Lancet 1999, 354, 407-414.
4. Klee, G.G. Cobalamin and Folate Evaluation, Measurement of Methylmalonic Acid and Homocysteine vs Vitamin B(12) and Folate. Clin. Chem. 2000, 46 (8 Pt 2), 1277-1283.
5. Ubbink, J.B. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia. J. Inherit. Metab. Dis. 1997, 20(2), 316-325.
6. Kang, S.S.; Wong, P.; Susmano, A.; Sora, J.; Norusis, M.; Ruggle, N. Thermolabile methylenetetrahydrofolate reductase, an inherited risk factor for coronary artery disease. Am. J. Hum. Genet. 1991, 48, 536-545.
7. Rozen, R.; Jacques, P.; Bostom, A.; Ellison, C.; Williams, R.; Rosenberg, L. Interaction of a common mutation in methylenetetrahydrofolate reductase with low folate status in hyperhomocyst(e)inemia. Am. J. Hum. Gent. 1995, 56, 142-150.
8. Frosst, P.; Blom, H.J.; Milos, R.; Goyette, P.; Sheppard, C.A.; Matthews, R.G.; Boers, G.J.; Den Heijer, M.; Kluijtmans, L.A.; van der Heuvel, L.P. A candidate genetic risk factor for vascular disease, a common mutation in methylenetetra-hydrofolate reductase. Nat. Genet. 1995, 10, 111-113.
9. Hassan, A.; Marcus, H.S. Genetics and ischaemic stroke. Brain 2000, 123, 1784-1811.
10. Mager, A.; Lalezari, S.; Shohat, T; Birnbaum, Y.; Adler, Y.; Magal, N.; Shohat, M. Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease. Circulation 1999, 100, 2406-2410.
11. Ueland, P.M.; Hustad, S.; Schneede, J.; Refsum, H.; Vollset, S.E. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol. Sci. 2001, 22 (4), 195-201.
12. McCully, K.S. Vascular pathology of homocyst(e)inemia, implications for the pathogenisis of arteriosclerosis. Am. J. Pathol. 1969, 56, 111-128.
13. Wilcken, D.; Wilcken, B. The pathogenesis of coronary heart disease. A possible role for methionine. J. Clin. Invest. 1976, 57, 211-215.
14. Graham, I.M.; Daly, L.E.; Refsum, H.M.; Robinson, K.; Brattstrom, L.E.; Ueland, P.M.; Palma-Reis, R.J.; Boers, G.H.; Sheahan, R.G.; Israelsson, B.; Uiterwaal, C.S.; Meleady, R.; McMaster, D.; Verhoef, P.; Witterman, J.; Rubba, P.; Bellet, H.; Wautrecht, J.C.; de Valk, H.W.; Sales Luis, A.C.; Parrot-Rouland, F.M.; Tan, K.S.; Higgins, I.; Garcon, D.; Medrano, M.J.; Candito, M.; Evans, A.E.; Andria, G. Plasma homocyst(e)ineas a risk factor for vascular disease. The european concerted action project. JAMA 1997, 277, 1775-1781.
15. Boushey, C.J.; Beresford, S.A.; Omenn, G.S.; Motulsky, A.G. A quantitative assessment of plasma homocyst(e)ineas a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274, 1049-1057.
16. Parnetti, L.; Bottiglieri, T.; Lowenthal, D. Role of homocysteine in age-related vascular and non-vascular diseases. Aging (Milano) 1997, 9, 241-257.
17. Nygård, O.; Nordrehaug, J.E.; Refsum, H.; Ueland, P.M.; Farstad, M.; Vollset, S.E. Plasma homocyst(e)ine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 1997, 337, 230-236.
18. Verhoef, P. Hyperhomocyst(e)inemia and risk of vascular disease in women. Semin. Thromb. Hemost. 2000, 26, 325-334.
19. Alfthan, G.; Pekkanen, J.; Jauhiainen, M.; Pitkaniemi, J.; Karvonen, M.; Tuomilehto, J.; Salonen, J.T.; Ehnholm, C. Relation of Serum Homocyst(e)ine and Lipoprotein(a) Concentrations to Atherosclerotic Disease in a Prospective Finnish Population Based Study. Atherosclerosis 1994, 106 (1), 9-19.
20. Brattstrom, L.E.; Hardebo, J.E.; Hultberg, B.L. Moderate homocyst(e)inemia-a possible risk factor for arterioscleroticcerebrovascular disease. Stroke 1984, 15, 1012-1016.
21. Brattstrom, L.; Israelsson, B.; Norrving, B.; Bergqvist, D.; Thorne, J.; Hultberg, B.; Hamfelt, A. Impaired homocyst(e)inemetabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 1990, 8, 51-60.
22. Brattstrom, L.; Lindgren, A.; Israelsson, B.; Malinow, M.R.; Norrving, B.; Upson, B.; Hamfelt, A. Hyperhomocysteinaemia in stroke, prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur. J. Clin. Invest. 1992, 22 (3), 214-221.
23. Coull, B.M.; Malinow, M.R.; Beamer, N.; Sexton, G.; Nordt, F.; de Garmo, P. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 1990, 21, 572-576.
24. Yoo, J.H.; Chung, C.S.; Kang, S.S. Relation of plasma homocyst(e)ine to cerebral infarction and cerebralatherosclerosis. Stroke 1998, 29 (12), 2478-2483.
25. Eikelboom, J.W.; Hankey, G.J.; Anand, S.S. Lofthouse, E. Staples, N.; Baker, R.I. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000, 31 (5), 1069-1075.
26. Harker, L.A.; Slichter, J.; Scott, C.R.; Russell, R. Homocystinemia. Vascular injury and arterial thrombosis. N. Engl. J. Med. 1974, 291, 537-543.
27. Stamler, J.S.; Osborne, J.A.; Jaraki, O.; Rabbani, L.E.; Mullins, M.; Singel, D.; Loscalzo, J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factors and related oxides of nitrogen. J. Clin. Invest. 1993, 91, 308-318.
28. Chao, C.L.; Kuo, T.L.; Lee, Y.T. Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults. Circulation 2000, 101, 485-490.
29. Lentz, S.R.; Sobey, C.G.; Piegors, D.J.; Bhopatkar, M.Y.; Faraci, F.M.; Malinow, M.R.; Heistadt, D.D. Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia. J. Clin. Invest. 1996, 98, 24-29.
30. Wall, R.T.; Harlan, J.M.; Harker, L.A.; Striker, G.F. Homocysteine-Induced endothelial cell injury in vitro, a model for the study of vascular injury. Thromb. Res. 1980, 18, 113-121.
31. Woo, K.S.; Chook, P.; Lolin, Y.I.; Cheung, A.S.; Chan, L.T.; Sun, Y.Y.; Sanderson, J.E.; Metreweli, C.; Celermajer, D.S. Hyperhomocysteinemia is a risk factor for endothelial dysfunction in humans. Circulation 1997, 96, 2542-2544.
32. Tawakol, A.; Omland, T.; Gerhard, M.; Wu, J.T.; Creager, M.A. Hyperhomocysteinemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997, 95, 1119-1121.
33. Starkebaum, G.; Harlan, J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 1986, 77, 1370-1376.
34. Ross, R. The pathogenesis of atherosclerosis, a perspective for the 1990s. Nature 1993, 362, 801-809.
35. McQuillan, B.M.; Beilby, J.P.; Nidorf, M.; Thompson, P.L.; Hung, J. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 1999, 99 (18), 2361-2363.
36. Okamura, T.; Kitamura, A.; Moriyama, Y.; Imano, H.; Sato, S.; Terao, A.; Naito, Y.; Nakagawa, Y.; Kiyama, M.; Tamura, Y.; Iida, M.; Suzuki, H.; Komachi, Y. Plasma level of homocysteine is correlated to extracranial carotid-artery atherosclerosis in non-hypertensive Japanese. J. Cardiovasc. Risk 1999, 6, 371-377.
37. Gallai, V.; Caso, V.; Paciaroni, M.; Cardaioli, G.; Arning, E.; Bottiglieri, T.; Parnetti, L. Mild hyperhomocyst(e)inemia, a possible risk factor for cervical artery dissection. Stroke 2001, 32 (3), 714-718.
38. Harker, L.A.; Ross, R.; Slichter, S.J.; Scott, C.R. Homocysteine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 1976, 58, 731-741.
39. Hart, R.C.; Easton, J.D. Dissections. Stroke 1985, 16, 925-927.